Source comparison
BPC-157 vs TB-500: Head to Head
Molecular weight 1,419.53 Da 4,963.44 Da Amino acids 15 43 Source protein Human gastric juice Thymosin beta-4 Half-life Under 30 minutes ~2 hours Typical dose 250-500mcg 2-5mg Dosing frequency 1-2x daily 2-3x weekly Primary mechanism VEGFR2/angiogenesis, NO mo
This comparison does not assign a generated winner or score.
- Molecular weight
- 1,419.53 Da
- 4,963.44 Da
- Amino acids
- 15
- 43
- Source protein
- Human gastric juice
- Thymosin beta-4
- Half-life
- Under 30 minutes
- ~2 hours
- Typical dose
- 250-500mcg
- 2-5mg
- Dosing frequency
- 1-2x daily
- 2-3x weekly
- Primary mechanism
- VEGFR2/angiogenesis, NO modulation
- Actin sequestration, cell migration
- Best application
- Localized injury, gut healing
- Systemic repair, muscle regeneration
- Human trials
- 3 pilot studies (under 30 subjects)
- Phase I, II, III (100+ subjects)
- FDA status
- Category 2 (restricted)
- Not scheduled
- WADA status
- Prohibited (S0)
- Prohibited
- The pharmacokinetic difference explains why these peptides are dosed so differently. BPC-157 peaks fast and clears fast. TB-500 peaks later and lingers.